Olefinic hydrocarbons: a first risk estimate for ethene

Area of Science:

• Toxicology
• Pharmacokinetics
• Risk Assessment

Background:

• Ethene is commonly considered a simple asphyxiant.
• Ethene oxide is a known genotoxic agent.
• Understanding ethene's metabolic fate is crucial for risk assessment.

Purpose of the Study:

• To estimate the genotoxic risk of ethene based on ethene oxide pharmacokinetics.
• To compare the genotoxic risks of ethene and ethene oxide exposure.
• To evaluate appropriate occupational exposure limits for ethene.

Main Methods:

• Rats were exposed to ethene and ethene oxide.
• Pharmacokinetic parameters (Keq, Kst) for ethene oxide distribution were determined.
• Metabolism saturation of ethene was considered.
• Carcinogenicity data for ethene oxide were analyzed.

Main Results:

• Ethene exhalation of ethene oxide by rats allows risk estimation.
• 1000 ppm ethene exposure theoretically equals 7.5 ppm ethene oxide exposure.
• Ethene is not a simple asphyxiant.
• A 1 ppm ethene oxide TLV is consistent with a 100 ppm ethene TLV.

Conclusions:

• Ethene exposure carries a genotoxic risk.
• Pharmacokinetic modeling provides a basis for risk assessment.
• Occupational exposure limits should reflect the genotoxic potential of ethene.